The findings indicate that elevated preoperative levels of CA125, HE4, SII, NLR, PLR, and FAR, as well as decreased PNI levels, are associated with a higher probability of advanced ovarian cancer progression and lymph node metastasis. The gene discussed is WFDC2; the disease is metastatic malignant neoplasm in the lymph nodes.